| Marie Denise Gervais, MD | |
|
1611 Nw 12th Ave, Box 016960, Miami, FL 33136-1005 | |
| (305) 243-2882 | |
| (305) 243-8470 |
| Full Name | Marie Denise Gervais |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 1611 Nw 12th Ave, Miami, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023073855 | NPI | - | NPPES |
| 263426100 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | ME80992 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jackson Health System | Miami, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Miami | 3274795109 | 1781 |
News Archive
Dr. Olga Meave didn't mind the dry, 105-degree heat that scorched this Central Valley city on a recent afternoon. The sweltering summer days remind her of home in Sonora, Mexico. So do the people of the Valley — especially the Latino first-generation immigrants present here in large numbers, toiling in the fields or piloting big rigs laden with fruits and vegetables.
Today's U.S. Food and Drug Administration approval of ibrutinib to treat patients with mantle cell lymphoma is a significant advance for patients with this blood cancer. It was approved as a single agent for treatment of patients with MCL who have received at least one prior therapy.
A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma AG.
Canadian pharmaceutical company, AstraZeneca Canada Inc., has introduced a new NEXIUM® Patient Support program designed to give physicians and pharmacists the ability to take cost out of the equation in the patient's choice between NEXIUM® tablets and a generic esomeprazole product.
› Verified 8 days ago
| Entity Name | University Of Miami |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013967827 PECOS PAC ID: 3274795109 Enrollment ID: O20200406001006 |
News Archive
Dr. Olga Meave didn't mind the dry, 105-degree heat that scorched this Central Valley city on a recent afternoon. The sweltering summer days remind her of home in Sonora, Mexico. So do the people of the Valley — especially the Latino first-generation immigrants present here in large numbers, toiling in the fields or piloting big rigs laden with fruits and vegetables.
Today's U.S. Food and Drug Administration approval of ibrutinib to treat patients with mantle cell lymphoma is a significant advance for patients with this blood cancer. It was approved as a single agent for treatment of patients with MCL who have received at least one prior therapy.
A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma AG.
Canadian pharmaceutical company, AstraZeneca Canada Inc., has introduced a new NEXIUM® Patient Support program designed to give physicians and pharmacists the ability to take cost out of the equation in the patient's choice between NEXIUM® tablets and a generic esomeprazole product.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marie Denise Gervais, MD 1611 Nw 12th Ave, Box 016960, Miami, FL 33136-1005 Ph: (305) 243-2882 | Marie Denise Gervais, MD 1611 Nw 12th Ave, Box 016960, Miami, FL 33136-1005 Ph: (305) 243-2882 |
News Archive
Dr. Olga Meave didn't mind the dry, 105-degree heat that scorched this Central Valley city on a recent afternoon. The sweltering summer days remind her of home in Sonora, Mexico. So do the people of the Valley — especially the Latino first-generation immigrants present here in large numbers, toiling in the fields or piloting big rigs laden with fruits and vegetables.
Today's U.S. Food and Drug Administration approval of ibrutinib to treat patients with mantle cell lymphoma is a significant advance for patients with this blood cancer. It was approved as a single agent for treatment of patients with MCL who have received at least one prior therapy.
A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma AG.
Canadian pharmaceutical company, AstraZeneca Canada Inc., has introduced a new NEXIUM® Patient Support program designed to give physicians and pharmacists the ability to take cost out of the equation in the patient's choice between NEXIUM® tablets and a generic esomeprazole product.
› Verified 8 days ago
Rosabel Maria Bencomo, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 6840 Sw 40th St Ste 209, Miami, FL 33155 Phone: 786-222-8807 Fax: 305-763-8379 | |
Luis Mario Molina, MA Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15736 Sw 50th Ter, Miami, FL 33185 Phone: 786-294-2772 | |
Katherine Del Valle Tovar Sanchez, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3632 Nw 25th Ave, Miami, FL 33142 Phone: 305-900-5888 Fax: 786-422-1509 | |
Duxson Michel, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 15041 Sw 148th Ave, Miami, FL 33196 Phone: 305-283-7487 | |
Miss Jocelyn Arlene Perez, APRN, FNP-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 13913 Sw 46th Ter Apt A, Miami, FL 33175 Phone: 305-987-5062 | |
Elena Marta Pernas, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 11501 Sw 40th St, Miami, FL 33165 Phone: 305-642-5366 | |
Rodolfo Hanabergh, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7490 Sw 23rd St, 201, Miami, FL 33155 Phone: 786-615-3013 Fax: 786-953-7514 |